Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: mukoyama n. Cancers (Basel). 2018 Sep 26;10(10):356. doi: 10.3390/cancers10100356. Cancers (Basel). 2018. PMID: 30261620 Free PMC article. Review.
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.
Eissa IR, Naoe Y, Bustos-Villalobos I, Ichinose T, Tanaka M, Zhiwen W, Mukoyama N, Morimoto T, Miyajima N, Hitoki H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: mukoyama n. Front Oncol. 2017 Jul 14;7:149. doi: 10.3389/fonc.2017.00149. eCollection 2017. Front Oncol. 2017. PMID: 28770166 Free PMC article. Review.
Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.
Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H. Wu Z, et al. Among authors: mukoyama n. Mol Ther Oncolytics. 2019 May 13;13:107-115. doi: 10.1016/j.omto.2019.04.004. eCollection 2019 Jun 28. Mol Ther Oncolytics. 2019. PMID: 31193737 Free PMC article.
Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8+ PD-1- tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment.
Eissa IR, Mukoyama N, Abdelmoneim M, Naoe Y, Matsumura S, Bustos-Villalobos I, Ichinose T, Miyajima N, Morimoto D, Tanaka M, Fujimoto Y, Sone M, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: mukoyama n. Int J Cancer. 2021 Jul 1;149(1):214-227. doi: 10.1002/ijc.33550. Epub 2021 Mar 23. Int J Cancer. 2021. PMID: 33687756 Free article.
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model.
Miyajima N, Ragab Eissa I, Abdelmoneim M, Naoe Y, Ichinose T, Matsumura S, Bustos-Villalobos I, Mukoyama N, Morimoto D, Shibata M, Takeuchi D, Tsunoda N, Kikumori T, Tanaka M, Kodera Y, Kasuya H. Miyajima N, et al. Among authors: mukoyama n. Nagoya J Med Sci. 2021 Nov;83(4):683-696. doi: 10.18999/nagjms.83.4.683. Nagoya J Med Sci. 2021. PMID: 34916713 Free PMC article.
STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Sibal PA, Matsumura S, Ichinose T, Bustos-Villalobos I, Morimoto D, Eissa IR, Abdelmoneim M, Aboalela MAM, Mukoyama N, Tanaka M, Naoe Y, Kasuya H. Sibal PA, et al. Among authors: mukoyama n. Mol Oncol. 2024 May;18(5):1259-1277. doi: 10.1002/1878-0261.13603. Epub 2024 Feb 23. Mol Oncol. 2024. PMID: 38400597 Free PMC article.
33 results